Literature DB >> 25787863

Current understanding of nasal morphology and physiology as a drug delivery target.

Julie D Suman1.   

Abstract

The nasal cavity is both a target for locally and systemically acting medications. An adequate treatment for rhinosinusitis continues to be an unmet need. With the recent approval of intranasal medications for the treatment of pain, the nasal cavity continues to be a viable route for rapid uptake into the systemic circulation. Despite the opportunities, there is still a void in the knowledge of how therapeutic entities interact with the nasal epithelium. In addition, new opportunities in mucosal immunity via nasal vaccination as well as the elusive nose to brain uptake continue to drive innovation. To facilitate understanding of the issues involved that facilitate drug delivery in the nose, a review of nasal morphology and physiology is presented.

Entities:  

Year:  2013        PMID: 25787863     DOI: 10.1007/s13346-012-0121-z

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  63 in total

1.  Nasal delivery systems and their effect on deposition and absorption.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-01-05       Impact factor: 15.470

2.  The relationship between particle deposition in the anterior nasal passage and nasal passage characteristics.

Authors:  J Kesavan; R Bascom; B Laube; D L Swift
Journal:  J Aerosol Med       Date:  2000

Review 3.  Physicochemical and physiological considerations for efficient nose-to-brain targeting.

Authors:  Shiv Bahadur; Kamla Pathak
Journal:  Expert Opin Drug Deliv       Date:  2011-12-16       Impact factor: 6.648

4.  Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent.

Authors:  Andrew H Murr; Timothy L Smith; Peter H Hwang; Neil Bhattacharyya; Brent J Lanier; James W Stambaugh; Andrew S Mugglin
Journal:  Int Forum Allergy Rhinol       Date:  2011-02-08       Impact factor: 3.858

5.  Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.

Authors:  A S Harris; E Svensson; Z G Wagner; S Lethagen; I M Nilsson
Journal:  J Pharm Sci       Date:  1988-05       Impact factor: 3.534

Review 6.  Deposition of aerosol in the respiratory tract.

Authors:  J D Brain; P A Valberg
Journal:  Am Rev Respir Dis       Date:  1979-12

7.  Nasal mucociliary clearance under various conditions.

Authors:  Y Sakakura; K Ukai; Y Majima; S Murai; T Harada; Y Miyoshi
Journal:  Acta Otolaryngol       Date:  1983 Jul-Aug       Impact factor: 1.494

8.  ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.

Authors:  Jacquelyn Cruz McCabe; Franciscus Koppenhagen; Julian Blair; Xian-Ming Zeng
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-12-22       Impact factor: 2.849

Review 9.  Systemic effects of intranasal steroids: an endocrinologist's perspective.

Authors:  D B Allen
Journal:  J Allergy Clin Immunol       Date:  2000-10       Impact factor: 10.793

10.  Zicam-induced damage to mouse and human nasal tissue.

Authors:  Jae H Lim; Greg E Davis; Zhenshan Wang; Vicky Li; Yuping Wu; Tessa C Rue; Daniel R Storm
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more
  7 in total

1.  In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model.

Authors:  Namita Sawant; Maureen D Donovan
Journal:  Pharm Res       Date:  2018-03-26       Impact factor: 4.200

2.  Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.

Authors:  Tao Yu; Jane Chisholm; Woo Jin Choi; Abraham Anonuevo; Sarah Pulicare; Weixi Zhong; Minmin Chen; Colleen Fridley; Samuel K Lai; Laura M Ensign; Jung Soo Suk; Justin Hanes
Journal:  Adv Healthc Mater       Date:  2016-09-26       Impact factor: 9.933

3.  The nasal delivery of nanoencapsulated statins - an approach for brain delivery.

Authors:  Adryana Clementino; Mellissa Batger; Gabriela Garrastazu; Michele Pozzoli; Elena Del Favero; Valeria Rondelli; Bianca Gutfilen; Thiago Barboza; Maria B Sukkar; Sergio A L Souza; Laura Cantù; Fabio Sonvico
Journal:  Int J Nanomedicine       Date:  2016-12-07

4.  Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia.

Authors:  Fabio Fais; Reda Juskeviciene; Veronica Francardo; Stéphanie Mateos; Manuela Guyard; Cécile Viollet; Samuel Constant; Massimo Borelli; Ilja P Hohenfeld
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

5.  Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging.

Authors:  Nisha Singh; Mattia Veronese; Jim O'Doherty; Teresa Sementa; Salvatore Bongarzone; Diana Cash; Camilla Simmons; Marco Arcolin; Paul K Marsden; Antony Gee; Federico E Turkheimer
Journal:  Nucl Med Biol       Date:  2018-08-30       Impact factor: 2.408

6.  Regional deposition of the allergens and micro-aerosols in the healthy human nasal airways.

Authors:  Mohammad Hazeri; Mohammad Faramarzi; Sasan Sadrizadeh; Goodarz Ahmadi; Omid Abouali
Journal:  J Aerosol Sci       Date:  2020-10-19       Impact factor: 3.433

7.  Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects.

Authors:  Marie Trenkel; Regina Scherließ
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.